Two analytical methods for assessing regional glucography with positron emission tomography were compared in 16 patients with schizophrenia and 11 patients with affective disorders. Patients were off all medication a minimum of 14 days and an average of 39.8 days. The subjects were administered fluorine-18-labeled 2-deoxyglucose just before receiving a 34-minute one-per-second series of unpleasant electrical stimuli to their right forearm while resting with their eyes closed in a darkened, acoustically attenuated psychophysiological testing chamber. Following monitored stimulation in the controlled environment, the subjects were scanned and the images were converted to values of glucose use in micromoles per 100 grams per minute, according to Sokoloff's model. Data were analyzed by a four-way analysis of variance (ANOVA) for independent groups (normal subjects, schizophrenic patients, and patients with affective disorders) and for repeated measures of slice level (supraventricular, midventricular , and infraventricular ), hemisphere (right, left), and anteroposterior position (four sectors). Normal individuals and patient groups both showed a significant anteroposterior gradient in glucose use, with the highest values in the sector farthest to the front. Patients with schizophrenia and those with affective illnesses showed less of an anteroposterior gradient than normal individuals, especially at superior levels, which was statistically confirmed by ANOVA. Neither the group differences in whole-brain glucose use nor the left-right asymmetries reached statistical significance. A second technique, involving reconstruction of the lateral cortical surface, also revealed differences between schizophrenics and normal individuals in the superior frontal cortex. These results are consistent with our earlier reports of a relative hypofrontal function in schizophrenia compared with controls; they also extend the finding to the affective illnesses, the other group of major psychoses.

This chapter presents the study that directly measured local cerebral glucose use by positron emission tomography (PET) with simultaneous recording of EEG from 16 electrodes spaced over the left hemisphere to maximize spatial resolution. Simultaneous cerebral glucography with positron emission tomography and topographic quantitative electroencephalography is carried out in six normal volunteers. The presence of resting occipital alpha activity is associated with relatively low glucose use consistent with the phenomenon of alpha blocking with visual input. Higher EEG amplitude is associated with higher glucose use in some posterior and central regions. The harmlessness, repeatability, and low cost of EEG topography give it some advantages over the high cost of PET or isotopic regional blood flow techniques. Extended studies are further necessary to define regional relationships; simultaneous PET and EEG studies are able to better characterize metabolic information available in the scalp electrical activity.

Local cerebral uptake of deoxyglucose labeled with fluorine 18 was measured by positron emission tomography in 16 patients with schizophrenia and 11 patients with affective disorder. Patients received no medication a minimum of 14 days and an average of 39.8 days. The subjects were administered the deoxyglucose 18F just before receiving a 34-minute 1/s series of unpleasant electrical stimuli to the right forearm while resting with eyes closed in a darkened, acoustically attenuated psychophysiologic testing chamber. Following monitored stimulation in the controlled environment, subjects were scanned and images converted to values of glucose use in micromoles per 100 g per minute according to Sokoloff's model. Data were analyzed with a four-way analysis of variance (ANOVA) with independent groups (normals, schizophrenics, and affectives) and repeated measures for slice level (supraventricular, midventricular, and infraventricular), hemisphere (right, left), and anteroposterior position (four sectors). Both normal subjects and patients showed a significant anteroposterior gradient in glucose use with highest values in the frontmost sector. Patients both with schizophrenia and with affective illness showed less of an anteroposterior gradient especially at superior levels, which was statistically confirmed by ANOVA. Absolute glucose levels in patients, which were actually higher in posterior regions rather than lower in frontal regions, were the largest contributors to the effect. Neither group differences in whole brain glucose use nor left-right asymmetries reached statistical significance. These results are consistent with our earlier reports of a relative hypofrontal function in schizophrenia compared with controls. This report extends this finding to affective illness, sharing a lack of diagnostic specificity with many biologic measures.

Annals of the New York Academy of SciencesVolume 398, Issue 1 p. 352-365 ROLE OF OPIOID PEPTIDES IN DISORDERS OF ATTENTION IN PSYCHPATHOLOGY M. S. Buchsbaum, M. S. Buchsbaum Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this authorV. I. Reus, V. I. Reus Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this authorG. C. Davis, G. C. Davis Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this authorH. H. Holcomb, H. H. Holcomb Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this authorJ. Cappelletti, J. Cappelletti Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this authorE. Silberman, E. Silberman Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this author M. S. Buchsbaum, M. S. Buchsbaum Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this authorV. I. Reus, V. I. Reus Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this authorG. C. Davis, G. C. Davis Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this authorH. H. Holcomb, H. H. Holcomb Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this authorJ. Cappelletti, J. Cappelletti Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this authorE. Silberman, E. Silberman Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20205Search for more papers by this author First published: December 1982 https://doi.org/10.1111/j.1749-6632.1982.tb39506.xCitations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume398, Issue1Opioids in Mental Illness: Theories, Clinical Observations, and Treatment PossibilitiesDecember 1982Pages 352-365 RelatedInformation

This report describes an integrated anatomical, electrophysiological and data management system for presenting cortical surface distribution maps. Approximately equal area projections (lateral and top) were constructed from a cross-sectional whole head atlas. Anatomical landmarks (major sulcus and gyrus locations) were also located on the outline. The outline and weights for interpolation are stored in the computer, with software for map generation directly from multilead EEG or evoked potential data. Electrode position and number can be easily varied and mapped onto any shaped space using the same program. Data derived from other sources such as xenon blood flow, brain scans or positron emission tomography can similarly be presented. The program uses a laboratory computer and emphasizes simplicity of data management and a mapping algorithm which is applicable to many forms of data.

AbstractBuchsbaum, M.S., J. Cappelletti, R. Coppola, F. Regal, A. C. King, and D. P. van Kammen: New methods to determine the CNS effects of antigeriatric compounds: EEG topography and glucose use. Drug Dev. Res. 2:489–496, 1982.It has previously been possible to measure regional glucose use in the cerebral cortex in animals only with autoradiographic techniques. With the advent of position emission tomography (PET) using (18F‐2DG) 18F‐2‐deoxyglucose, it is now possible to assess local glucose uptake in μmol/100 g tissue/min in normal volunteers or patients. The PET technique is complex and costly and cannot be repeated frequently because of the radiation dosage. However, local glucose use is closely tied to cerebral blood flow, and studies have related blood flow to EEG frequency measures. In this study, we have simultaneously investigated local glucose metabolism using 18F‐2DG with PET and EEG frequency with 16‐lead topographic mapping in six normal controls. Subjects sat in an acoustically treated darkened room with eyes closed for 10 min prior to, and 30 min following injection of 3–5 mCi 18F‐2DG. Following uptake, seven to eight horizontal scans parallel to the canthomeatal line were made. EEG recordings are made beginning 1 min after injection of the isotope and continuing for 30 min with 12 standard 10/20 system points on the left hemisphere and midline, and 4 additional points between existing posterior leads. Ten‐second EEG epochs are edited for artifacts and then analyzed by fast Fourier transform techniques. Using a cross‐sectional whole‐head atlas, a standardized, approximately equal‐area two‐dimensional representation of a lateral view of the brain was developed and 10/20 system scalp coordinates were projected onto it. EEG power estimates are interpolated for all points on this brain map. Using digital techniques, a 1‐cm‐thick cortical strip is peeled off each PET, slice and conformed to the lateral brain view, and values between strips are interpolated. The result is two simultaneously obtained electrophysiologic and metabolic lateral views of brain function displayed in gray‐scale values represented by dot density. In some subjects with eyes closed, alpha power is high in low glucose‐use regions, such as the occiput. Temporal regions appear low both in glucose use and in most power bands. Parallels between alpha distribution and glucose use are illustrated.

Local cerebral uptake of deoxyglucose labeled with fluorine 18 was measured by positron-emission tomography in eight patients with schizophrenia who were not receiving medication and in six age-matched normal volunteers. Subjects sat in an acoustically treated, darkened room with eyes closed after injection of 3 to 5 mCi of deoxyglucose 18F. After uptake, seven to eight horizontal brain scans parallel to the canthomeatal line were done. Scans were treated digitally, with a 2.3-cm strip peeled off each slice and ratios to whole-slice activity computed. Patients with schizophrenia showed lower ratios in the frontal cortex, indicating relatively lower glucose use than normal control subjects; this was consistent with previously reported studies of regional cerebral blood flow. Patients also showed diminished ratios for a 2.3-cm square that was positioned over central gray-matter areas on the left but not on the right side. These findings are preliminary; issues of control of mental activity, brain structure identification, and biologic and anatomic heterogeneity of schizophrenia remain to be explored.

Multilead EEG recordings result in a large volume of data that is not easily digested. It is now possible to produce grey scale maps that show the topographical relation of electrical activity from different recording sites. These maps form a succinct presentation of multilead EEG that more readily shows the spatial relations of activity than standard polygraph recordings. A laboratory computer system rapidly generates surface distribution maps derived from measures related to electrical activity. The system is flexible in allowing specification of the number of electrodes and their placement. A two dimensional projection is utilized which results in a naturalistic view of the final map.